Research Impact
Associate Professor Varey is a world leader in risk prediction of melanoma. Associate Professor Varey’s research and leadership has established the first globally accessible, online platform for comprehensive melanoma risk prediction; the Melanoma Institute Australia's 'melanomarisk.org.au’.
Clinicians managing patients with melanoma access this platform around 200,000 times a year across the globe. The most widely used of these six tools is one used to estimate the risk of a melanoma having spread to the lymph nodes, the 'Sentinel Node Metastasis Risk' calculator, which is used over 130,000 times a year.
Associate Professor Varey’s vision and current research drive is the development of several further tools which are currently under development. This will lead to further benefits in best practice management and diagnosis of melanoma sufferers globally.
Associate Professor Varey regularly presents his research at both Australian and International conferences.
If you are interested in exploring how you would like to make a compelling impact to this research, in a way that is deeply meaningful to you, please request Associate Professor Varey provide you with an email introduction to Dr Shayan Quinlan. Dr Quinlan supports University of Sydney clinician researchers and their patients (or other interested parties) in exploring how to create a bespoke gift that is most meaningful to the donor. The utmost care is given to patient confidentiality.
Further areas of research include:
Work on blood vessel growth inhibition/stimulation ('angiogenesis') in cancer, with several publications and awards, including British Oncological Association "Young Investigator of the Year' and Royal College of Surgeons of England 'Hunterian Professor'.
Establishment of the Mallet finger Extension Relative Motion Splint (MERMS) study: a randomised controlled trial to determine if a novel splinting combination can help a type of finger injury known as 'mallet finger'.
Part of the team to first demonstrate an effect of mobile phone radiation on humans, with a randomised controlled trial finding that it improved peoples’ choice reaction times ie hitting a red button when ‘no’ appeared or a green button when ‘yes’ appeared on the screen.